AtriCure risk/reward most positive in three years, says Barrington

Theflyonthewall.com – Mon, Jul 2, 2012 2:01 PM EDT

RELATED QUOTES

SymbolPriceChange
ATRC9.140.15

After meeting with AtriCure's CEO David Drachman, Barrington said it believes the risk/reward for shares has not been this positive in three years. The firm reiterates an Outperform rating on the stock with a $17 price target.

  •  
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
    Save List to Portfolio »

  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.

    Trading Center

    Yahoo! Finance on Facebook

    POLL

    Should Chinese companies be rebuilding America's infrastructure?

    Loading...
    Poll Choice Options

    See results

    17 hours remaining